Welcome to our dedicated page for NHIV news (Ticker: NHIV), a resource for investors and traders seeking the latest updates and insights on NHIV stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NHIV's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NHIV's position in the market.
NewHold Investment Corp IV (NYSE:NHIV) closed its initial public offering on April 16, 2026, raising $201,250,000 from 20,125,000 units at $10.00 each, including full exercise of a 2,625,000-unit over-allotment option. Each unit contains one Class A ordinary share and one-third of a warrant.
Units trade on Nasdaq Global Market as NHIVU; once separated, shares and warrants are expected to trade as NHIV and NHIVW. Proceeds are intended to fund the company’s initial business combination.
NewHold Investment Corp IV (NHIV) priced a $175.0 million initial public offering of 17,500,000 units at $10.00 per unit on April 14, 2026, with each unit containing one Class A ordinary share and one-third of a redeemable warrant.
Units begin trading on Nasdaq Global Market as NHIVU on April 15, 2026; Class A shares and warrants are expected to trade as NHIV and NHIVW after separation. The underwriter has a 45-day 15% over-allotment option to purchase up to 2,625,000 additional units. The offering is expected to close April 16, 2026.